Treatments Exploring Second-Generation CLL Inhibitors Philip Thompson, MB, BS, Andrew Schorr, Nicole Lamanna, MD
Treatments When Should Transplant Be Considered for CLL Patients? Philip Thompson, MB, BS, Andrew Schorr, Nicole Lamanna, MD
Treatments Why Is Venetoclax Approved for Only a Subset of Patients? Philip Thompson, MB, BS, Andrew Schorr, Nicole Lamanna, MD
Living With MPNs Everyone's MPN Is Different: Finding the Best Treatment Plan for You John Mascarenhas, MD, Mark Heaney, MD, PhD, Andrew Schorr
Treatments Expert Update: The Status of JAK Inhibitors in Development John Mascarenhas, MD, Mark Heaney, MD, PhD, Andrew Schorr
Ask the Expert Is Occasional Spleen Pain Normal for an MPN Patient Without Splenomegaly? Mark Heaney, MD, PhD, Andrew Schorr